These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 37405520)

  • 1. Minireview: functional roles of tissue kallikrein, kinins, and kallikrein-related peptidases in lung cancer.
    Stuardo-Parada A; López-Muñoz R; Villarroel-Espindola F; Figueroa CD; Ehrenfeld P
    Med Oncol; 2023 Jul; 40(8):224. PubMed ID: 37405520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of tissue kallikrein and kallikrein-related peptidases in breast cancer.
    Figueroa CD; Molina L; Bhoola KD; Ehrenfeld P
    Biol Chem; 2018 Sep; 399(9):937-957. PubMed ID: 29885274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human tissue kallikreins: the cancer biomarker family.
    Paliouras M; Borgono C; Diamandis EP
    Cancer Lett; 2007 Apr; 249(1):61-79. PubMed ID: 17275179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional interrelationships between the kallikrein-related peptidases family and the classical kinin system in the human neutrophil.
    Ehrenfeld P; Bhoola KD; Matus CE; Figueroa CD
    Biol Chem; 2018 Sep; 399(9):925-935. PubMed ID: 29883315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and bioregulation of the kallikrein-related peptidases family in the human neutrophil.
    Lizama AJ; Andrade Y; Colivoro P; Sarmiento J; Matus CE; Gonzalez CB; Bhoola KD; Ehrenfeld P; Figueroa CD
    Innate Immun; 2015 Aug; 21(6):575-86. PubMed ID: 25563717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioregulation of kallikrein-related peptidases 6, 10 and 11 by the kinin B₁ receptor in breast cancer cells.
    Ehrenfeld P; Manso L; Pavicic MF; Matus CE; Borquez C; Lizama A; Sarmiento J; Poblete MT; Bhoola KD; Naran A; Figueroa CD
    Anticancer Res; 2014 Dec; 34(12):6925-38. PubMed ID: 25503118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies.
    Avgeris M; Scorilas A
    Expert Opin Ther Targets; 2016 Jul; 20(7):801-18. PubMed ID: 26941073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kallikrein-related peptidases in lung diseases.
    Lenga Ma Bonda W; Iochmann S; Magnen M; Courty Y; Reverdiau P
    Biol Chem; 2018 Sep; 399(9):959-971. PubMed ID: 29604204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers.
    Emami N; Diamandis EP
    Clin Chem; 2008 Oct; 54(10):1600-7. PubMed ID: 18687738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kallikrein-related peptidase family: Dysregulation and functions during cancer progression.
    Kryza T; Silva ML; Loessner D; Heuzé-Vourc'h N; Clements JA
    Biochimie; 2016 Mar; 122():283-99. PubMed ID: 26343558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological and pathological roles of kallikrein-related peptidases in the epidermis.
    Kishibe M
    J Dermatol Sci; 2019 Aug; 95(2):50-55. PubMed ID: 31279501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma.
    Planque C; Li L; Zheng Y; Soosaipillai A; Reckamp K; Chia D; Diamandis EP; Goodglick L
    Clin Cancer Res; 2008 Mar; 14(5):1355-62. PubMed ID: 18316555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer.
    Pampalakis G; Sotiropoulou G
    Biochim Biophys Acta; 2007 Sep; 1776(1):22-31. PubMed ID: 17629406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulation of the kallikrein-kinin system in bronchoalveolar lavage fluid of patients with severe COVID-19.
    Martens CP; Van Mol P; Wauters J; Wauters E; Gangnus T; Noppen B; Callewaert H; Feyen JHM; Liesenborghs L; Heylen E; Jansen S; Pereira LCV; Kraisin S; Guler I; Engelen MM; Ockerman A; Van Herck A; Vos R; Vandenbriele C; Meersseman P; Hermans G; Wilmer A; Martinod K; Burckhardt BB; Vanhove M; Jacquemin M; Verhamme P; Neyts J; Vanassche T
    EBioMedicine; 2022 Sep; 83():104195. PubMed ID: 35939907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The family of kallikrein-related peptidases and kinin peptides as modulators of epidermal homeostasis.
    Matus CE; Ehrenfeld P; Figueroa CD
    Am J Physiol Cell Physiol; 2022 Oct; 323(4):C1070-C1087. PubMed ID: 35993513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of the plasma and tissue kallikreins, and their alternative splicing isoforms.
    Koumandou VL; Scorilas A
    PLoS One; 2013; 8(7):e68074. PubMed ID: 23874499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value and biological role of the kallikrein-related peptidases in human malignancies.
    Mavridis K; Scorilas A
    Future Oncol; 2010 Feb; 6(2):269-85. PubMed ID: 20146586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
    van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
    Elife; 2020 Apr; 9():. PubMed ID: 32338605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkers.
    Kontos CK; Scorilas A
    Clin Chem Lab Med; 2012 Nov; 50(11):1877-91. PubMed ID: 23093268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of hepatocyte growth factor activator zymogen (pro-HGFA) by human kallikrein 1-related peptidases.
    Mukai S; Fukushima T; Naka D; Tanaka H; Osada Y; Kataoka H
    FEBS J; 2008 Mar; 275(5):1003-17. PubMed ID: 18221492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.